Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

CubicFarm closes first tranche of private placement

CubicFarm has closed the first tranche of its non-brokered private placement of units of the company.

Pursuant to the Private Placement, the company intends to issue up to 10,250,000 Units at a price of C$0.20 per Unit for gross proceeds of up to C$2.5 million. Each Unit will consist of one common share of the company and one-half of one common share purchase warrant (the “Warrants“). Each Warrant will entitle the holder thereof to acquire one Common Share of the company at an exercise price of C$0.25 (the “Exercise Price“) per Common Share for 24 months from the date of issuance.

Under the First Tranche, the company issued 4,505,502 Units for C$0.20 per Unit for gross proceeds of approximately C$900,000.

The company intends to use the proceeds of the First Tranche for general working capital, approximately 360,000, as partial repayment of its secured debt and for general administrative purposes.

The securities offered in the First Tranche are subject to a four-month and a-day transfer restriction from the date of issuance, expiring on June 10, 2024, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada.

Pursuant to the Private Placement, John de Jonge (the “Investor”) is an insider of the company by virtue of being the interim Chief Executive Officer of the company. The Investor participate din the First Tranche of the Private Placement by purchasing 250,000 Units and, accordingly, this purchase constitutes a related party transaction as defined under Multilateral Instrument 61-101 – Protection of Minority Securityholders in Special Transactions (“MI 61-101”). The company is exempt from the formal valuation and minority approval requirement under MI 61-101 as the fair market value of the insider’s participation in the aggregate in the Private Placement does not exceed more than 25% of the market capitalization of the company, as set forth in Sections 5.5(a) and 5.7(1)(a) of MI 61-101. The company has not filed a material change report more than twenty-one (21) days before the closing date of the First Tranche of the Private Placement, as the details of the First Tranche were not finalized until February 8, 2024, and the company wished to close the First Tranche as soon as practicable.

Completion of the Private Placement remains subject to the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange.

For more information:
Tel.: 1-888-280-9076
[email protected]

Publication date: